Are the Immune Properties of Mesenchymal Stem Cells from Wharton’s Jelly Maintained during Chondrogenic Differentiation?

Archive ouverte

Voisin, Charlotte | Cauchois, Ghislaine | Reppel, Loïc | Laroye, Caroline | Louarn, Laetitia | Schenowitz, Chantal | Sonon, Paulin | Poras, Isabelle | Wang, Valentine | D. Carosella, Edgardo | Benkirane-Jessel, Nadia | Moreau, Philippe | Rouas-Freiss, Nathalie | Bensoussan, Danièle | Huselstein, Céline

Edité par CCSD ; MDPI -

International audience. Background: Umbilical mesenchymal stem/stromal cells (MSCs), and especially those derived from Wharton’s jelly (WJ), are a promising engineering tool for tissue repair in an allogeneic context. This is due to their differentiation capacity and immunological properties, like their immunomodulatory potential and paracrine activity. Hence, these cells may be considered an Advanced Therapy Medicinal Product (ATMP). The purpose of this work was to differentiate MSCs from WJ (WJ-MSCs) into chondrocytes using a scaffold and to evaluate, in vitro, the immunomodulatory capacities of WJ-MSCs in an allogeneic and inflammatory context, mimicked by IFN-γ and TNF-α priming during the chondrogenic differentiation. Methods: Scaffolds were made from hydrogel composed by alginate enriched in hyaluronic acid (Alg/HA). Chondrogenic differentiation, immunological function, phenotype expression, but also secreted soluble factors were the different parameters followed during 28 days of culture. Results: During chondrocyte differentiation, even in an allogeneic context, WJ-MSCs remained unable to establish the immunological synapse or to induce T cell alloproliferation. Moreover, interestingly, paracrine activity and functional immunomodulation were maintained during cell differentiation. Conclusion: These results show that WJ-MSCs remained hypoimmunogenic and retained immunomodulatory properties even when they had undergone chondrocyte differentiation.

Consulter en ligne

Suggestions

Du même auteur

Identification of immunomodulatory capacities of mesenchymal stem cells derived from Wharton’s jelly during cell differentiation

Archive ouverte | Voisin, Charlotte | CCSD

International audience

Mesenchymal Stem Cells Derived from Human Bone Marrow and Adipose Tissue Maintain Their Immunosuppressive Properties After Chondrogenic Differentiation: Role of HLA-G

Archive ouverte | Du, Wen-Jing | CCSD

International audience. Mesenchymal stem cells (MSC) have emerged as alternative sources of stem cells for regenerative medicine because of their multipotency and strong immune-regulatory properties. Also, human leu...

New advanced therapy medicinal product for cartilage defect treatment with extemporaneous association of a scaffold and Wharton's jelly mesenchymal stromal cells

Archive ouverte | Reppel, Loïc | CCSD

International audience. n the framework of an ANR project obtained in 2015, we propose to develop a new advancedtherapy medicinal product for cartilage defect treatment with extemporaneous association of ascaffold a...

Chargement des enrichissements...